On Thursday, January 12th, 2017, Renstar Medical Research was presented with the INC Research Site Award. This award, only given to select sites, recognizes Renstar for their accomplishments and contributions for over five years while participating on a clinical trial for psoriasis.
The award highlights a team approach in providing consistent, high quality work. This includes the clinical team, the data, regulatory, and recruitment departments, and the Renstar administration.
“I am grateful for the patients who are dedicated to helping improve the quality of life for others suffering with this disease,” said Mary Brantley, Lead Study Coordinator on many of Renstar’s dermatology studies.
As a recipient of this award, Renstar has proven they have the necessary processes in place to achieve the goals of maintaining data integrity while taking excellent care of the patients.
“I appreciate the trust our patients put in us, and I couldn’t be more proud of our team,” said Mary.